Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

ConditionSarcoma, Ewing

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorIstituto Ortopedico Rizzoli

About this trial

The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches

Eligibility criteria

Qualifiers

Male and female patients of any age diagnosed with Ewing sarcoma.

Signed, study-specific informed consent form for the BIOVES study (cancer patients)

Male and female patients of legal age without a cancer diagnosis.

Signed, study-specific informed consent form for the BIOVES study (non-cancer patients)

Disqualifiers

None

Trial design

Treatments tested in this trial

one blood sample
3 blood samples

Treatment groups

16 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Istituto Ortopedico Rizzoli

Lead sponsor

Source ClinicalTrials.gov